Chester County News and Community Website
PHILADELPHIA, PA— Researchers at The Wistar Institute, led by Jessie Villanueva, Ph.D., have made significant strides in combating treatment-resistant melanoma. Their latest discovery focuses on inhibiting the gene S6K2, a breakthrough …
Wistar Institute Uncovers New Strategy for Treating Resistant Melanoma Read More PHILADELPHIA, PA — The Wistar Institute has announced that two of its assistant professors, Dr. Nan Zhang and Dr. Noam Auslander, have been awarded a total of $1.2 million in …
Wistar Institute Researchers Secure $1.2 Million for Groundbreaking Cancer Studies Read More PHILADELPHIA, PA — The Wistar Institute, led by Dr. David B. Weiner, has announced successful preclinical tests of a groundbreaking immune therapy for glioblastoma, a highly aggressive brain cancer with …
Wistar Institute Develops Promising Immune Therapy for Glioblastoma Read More PHILADELPHIA, PA — The Wistar Institute has unveiled a groundbreaking approach to tackling ovarian cancer, potentially revolutionizing treatment outcomes for the deadliest of gynecological cancers. Led by Nan Zhang, Ph.D., …
Pioneering Discovery by The Wistar Institute Offers New Hope in Ovarian Cancer Treatment Read More PHILADELPHIA, PA — New research from The Wistar Institute and the Perelman School of Medicine has identified the RSAD2/Viperin gene as a potential target for future HIV treatments. This discovery could …
New Gene Target Offers Hope in HIV Research Read More PHILADELPHIA, PA — The Wistar Institute has made a significant breakthrough in understanding the role of Parkin, a protein traditionally associated with Parkinson’s disease, in the body’s immune response to cancer. …
Wistar Institute Breakthrough: Parkin Protein Revealed as a Game-Changer in Cancer Immunity! Read More PHILADELPHIA, PA — The Wistar Institute has announced a significant $24 million investment to establish a new HIV Cure and Viral Diseases Center. This initiative aims to move beyond current …
Wistar Institute Launches Ambitious HIV Cure Center Read More PHILADELPHIA, PA — Advanced clear cell renal cell carcinoma (ccRCC) is a formidable form of kidney cancer, causing an alarming mortality rate as even recent immunotherapies leave survival chances in …
New Hope for Tough Kidney Cancer: Reinventing Antibody Therapies Read More PHILADELPHIA, PA — Salient medical exploration at The Wistar Institute may have shed light on the role of the Epstein-Barr Virus (EBV) in the development of multiple sclerosis (MS). Paul …
Unlocking Epstein-Barr Virus Secrets: Potential Breakthrough in Battle Against Multiple Sclerosis Read More PHILADELPHIA, PA — The Wistar Institute announced a significant boost for its Biomedical Technician Training (BTT) Pre-apprenticeship Program, receiving a $649,971 grant from the National Science Foundation (NSF). This funding …
Wistar Institute Secures NSF Grant to Expand Biomedical Technician Training Program Read More